An upcoming short course being offered at DIA’s 2019 meeting (June 23-27) in San Diego will spotlight ways in which real-world evidence can potentially help clear an impasse between payers and drugmakers on pricing for innovative therapies.
The course, “Value Pricing Bootcamp: A Crash Course in How to Use Real World Evidence to Better Measure Outcomes and Evaluate New Innovative Therapies,” will take place in the first day of DIA 2019 between 1:30-5:30 p.m.
“It will highlight examples of how RWE can be better used to facilitate earlier access, measure outcomes, address value long term across the entire health system, and offer more creative pricing solutions to facilitate better patient access,” a description for the course states.
Featured topics include:
- Pricing and value case-studies on current clinical therapies such as CAR-T, IO checkpoint and HEP C;
- Interactive workshop discussions on various payment options; and
- An overview of the Italian outcomes system of reimbursement.